TIDMCSRT

RNS Number : 0727P

Consort Medical PLC

23 May 2018

23 May 2018

Consort Medical plc

Notice of Results

Consort Medical plc (LSE: CSRT) ("Consort", "Consort Medical" or the "Group"), a leading one-stop developer and manufacturer of drugs and premium drug delivery devices, will announce its financial results for the year ended 30 April 2018 on Thursday, 14 June 2018.

Enquiries:

 
 Consort Medical                Tel: +44 (0) 1442 867920 
 Jonathan Glenn - Chief 
  Executive Officer 
 Paul Hayes - Chief Financial 
  Officer 
 
 Investec Bank plc              Tel: +44 (0) 20 7597 
                                 5970 
 Gary Clarence 
 Carlton Nelson 
 
 RBC Capital Markets            Tel: +44 (0) 20 7653 
                                 4000 
 Marcus Jackson 
 Laura White 
 
 FTI Consulting                 Tel: +44 (0) 20 3727 
                                 1000 
 Ben Atwell / Simon Conway

About Consort Medical

Consort Medical plc is a leading one-stop developer and manufacturer of drugs and premium drug delivery devices. We partner with pharmaceutical businesses in providing innovative life improving treatments to patients across the world through two integrated activities:

The design, development and manufacture of high performance medical devices for inhaled, injectable, nasal and ocular drug delivery, as well as point of care diagnostics products.

The development, formulation and manufacture of active pharmaceutical ingredients (APIs) and finished dose drugs to the highest quality standards.

We employ over 2,000 people globally and are committed to investing in patient, clinician and customer driven innovation to create new treatments.

Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT) and is organised in two divisions: Bespak and Aesica. www.consortmedical.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NORBSGDUGGDBGIX

(END) Dow Jones Newswires

May 23, 2018 10:15 ET (14:15 GMT)

Consort Medical (LSE:CSRT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Consort Medical Charts.
Consort Medical (LSE:CSRT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Consort Medical Charts.